Both "Small Ball" and "Big Inning" Teams Are Progressing the Value of Antifungal Prophylaxis Among Patients With Hematologic Malignancy

Clin Infect Dis. 2021 May 18;72(10):1764-1766. doi: 10.1093/cid/ciaa569.

Author

Jo-Anne H Young¹

Affiliation

¹ Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

PMID: 32424426
DOI: 10.1093/cid/ciaa569

No abstract available

Keywords: antifungal prophylaxis; hematologic malignancy; isavuconazole; posaconazole.

Publication types

Editorial
Comment

MeSH terms

Antifungal Agents / therapeutic use
Hematologic Neoplasms* / complications
Hematologic Neoplasms* / drug therapy
Humans
Invasive Fungal Infections* / drug therapy
Invasive Fungal Infections* / prevention & control

Substances

Antifungal Agents